Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in guidelines on benign prostatic hyperplasia.

Jean J M C H de la Rosette1, Deric K E van der Schoot, Frans M J Debruyne

  • 1Department of Urology, University Medical Center, Nijmegen, The Netherlands. J.delaRosette@uro.azn.nl

Current Opinion in Urology
|December 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Festschrift essay to celebrate Dr. Michael Droller.

Urologic oncology·2025
Same author

Estetrol Inhibits the Prostate Cancer Tumor Stimulators FSH and IGF-1.

Journal of clinical medicine·2024
Same author

The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males.

Journal of the Endocrine Society·2024
Same author

Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia.

Expert opinion on drug safety·2023
Same author

The post-finasteride syndrome: possible etiological mechanisms and symptoms.

International journal of impotence research·2023
Same author

From BPH to male LUTS: a 20-year journey of the EAU guidelines.

Prostate cancer and prostatic diseases·2023

Healthcare guidelines standardize disease diagnosis and treatment. However, urologist preference and patient involvement significantly influence treatment choices, necessitating focus on treatment durability and cost-effectiveness.

Area of Science:

  • Healthcare Management
  • Clinical Practice Guidelines
  • Urology

Background:

  • Clinical guidelines aim to standardize disease diagnosis, treatment, and follow-up.
  • Guideline recommendations are based on clinical evidence, with patient assessment prioritizing non-invasive tests.
  • Treatment decisions are increasingly influenced by urologist preference and patient involvement.

Purpose of the Study:

  • To analyze the factors influencing treatment decisions in healthcare.
  • To highlight the importance of evidence-based practice versus personal preference.
  • To emphasize the need for data on treatment durability for cost-effective care.

Main Methods:

  • Review of existing healthcare guidelines and clinical practice standards.
  • Analysis of factors affecting treatment selection, including evidence, patient factors, and economic considerations.

Related Experiment Videos

  • Identification of limitations in current data regarding treatment durability.

    • Main Results:

    • Healthcare guidelines provide a framework for rationalizing patient care.
    • Treatment choices often deviate from guidelines due to urologist and patient preferences.
    • Limited data exists on the long-term durability of various treatments.

    Conclusions:

    • While guidelines promote evidence-based care, personal preferences play a significant role in urological treatment decisions.
    • Increased patient awareness and involvement are shaping treatment choices.
    • Further research on treatment durability is crucial for optimizing cost-effective healthcare delivery.